Chemotherapy combined with immunotherapy vs. chemotherapy: comparison of safety and efficacy in adjuvant therapy for intrahepatic cholangiocarcinoma - Quiz - MDSpire

Chemotherapy combined with immunotherapy vs. chemotherapy: comparison of safety and efficacy in adjuvant therapy for intrahepatic cholangiocarcinoma

  • By

  • Lu Yang

  • Haijing Zheng

  • Zhaolong Pan

  • Dongyang Li

  • Yunlong Cui

  • Huikai Li

  • Qiang Wu

  • Tianqiang Song

  • Qiang Li

  • Wei Zhang

  • June 22, 2026

  • 0 min

Share

Original Source(s)

Chemotherapy combined with immunotherapy vs. chemotherapy: comparison of safety and efficacy in adjuvant therapy for intrahepatic cholangiocarcinoma

  • by Lu Yang, Haijing Zheng, Zhaolong Pan, Dongyang Li, Yunlong Cui, Huikai Li, Qiang Wu, Tianqiang Song, Qiang Li, Wei Zhang

  • June 22, 2026

Related Content

Efficacy and safety of reduced-dose daratumumab plus bortezomib and dexamethasone (DVd-lite) in newly diagnosed MGRS patients

Breaking the sound barrier: global monoclonal antibody pharmacoequity

Reporting of Rurality, Deprivation, and Socioeconomic Characteristics in Cancer Clinical Trials: A Systematic